---
title: "Twilight Litaka Pharma Ltd (TWILITAKA) — Share Price, Financials & Analysis"
symbol: "TWILITAKA"
company: "Twilight Litaka Pharma Ltd"
canonical: "https://tapetide.com/stocks/TWILITAKA"
sector: "Healthcare"
industry: "Pharmaceuticals & Biotechnology"
generated_at: "2026-09-13T19:41:21.057Z"
---

# Twilight Litaka Pharma Ltd (TWILITAKA)

Canonical page: https://tapetide.com/stocks/TWILITAKA

## Company

- **Sector:** Healthcare
- **Industry:** Pharmaceuticals & Biotechnology
- **Macro Sector:** Healthcare
- **Stock Type:** EQUITY
- **Face Value:** ₹5
- **F&O Eligible:** No
- **Website:** twilightlitaka.com

## About

Twilight Litaka Pharma Limited, incorporated in India, Listed on the Bombay Stock  exchange Limited, and National Stock Exchange Limited, the company is engaged in Pharmaceuticals business

## Latest Price

## Key Insights

### Weaknesses

- Company has low interest coverage ratio.
- The company has delivered a poor sales growth of -38.9% over past five years.
- Company has high debtors of 2,342 days.
- Working capital days have increased from 467 days to 1,003 days

## Growth Rates

| Metric | 1Y | 3Y | 5Y |
| --- | --- | --- | --- |
| net income growth | 94% | — | — |
| revenue growth | -68% | -64% | -39% |

## Financial Statements

### Quarterly Results

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2013 | Jun 2013 | Sep 2013 | Dec 2013 | Mar 2014 | Jun 2014 | Sep 2014 | Dec 2014 | Mar 2015 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Sales | 20.29 | 11.05 | 10.01 | 9.26 | 9.06 | 3.17 | 2.3 | 4.35 | 2.77 |
| Expenses | 49.12 | 51.26 | 23.41 | 10.32 | 9.47 | 2.43 | 1.85 | 2.09 | 4.31 |
| Operating Profit | -28.83 | -40.21 | -13.4 | -1.06 | -0.41 | 0.74 | 0.45 | 2.26 | -1.54 |
| OPM % | -142.09 | -363.89 | -133.87 | -11.45 | -4.53 | 23.34 | 19.57 | 51.95 | -55.6 |
| Other Income | 0.09 | -0.34 | 0 | 0 | 0 | -125.45 | 0 | -18.75 | 0 |
| Interest | -26.86 | -6.86 | 0.16 | 0.13 | 0.12 | 0 | 0 | 0 | 0 |
| Depreciation | 1.26 | 1.16 | 1.1 | 1.08 | 1.02 | 1.24 | 1.21 | 0.02 | 2.45 |
| Profit before tax | -3.14 | -34.85 | -14.66 | -2.27 | -1.55 | -125.95 | -0.76 | -16.51 | -3.99 |
| Tax % | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Profit | -3.14 | -34.85 | -14.66 | -2.27 | -1.55 | -125.96 | -0.76 | -16.51 | -4 |
| EPS in Rs | -1.27 | -14.06 | -5.92 | -0.92 | -0.63 | -50.83 | -0.31 | -6.66 | -1.61 |

### Profit & Loss

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2006 | Mar 2007 | Mar 2008 | Mar 2009 | Mar 2010 | Mar 2011 | Mar 2012 | Jun 2013 15m | Jun 2014 | TTM |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Sales | 155 | 197 | 295 | 370 | 492 | 657 | 730 | 338 | 32 | 13 |
| Expenses | 139 | 171 | 257 | 322 | 425 | 559 | 662 | 379 | 40 | 11 |
| Operating Profit | 16 | 27 | 38 | 49 | 67 | 98 | 69 | -41 | -9 | 2 |
| OPM % | 10 | 13 | 13 | 13 | 14 | 15 | 9 | -12 | -28 | 15 |
| Other Income | 2 | 1 | 2 | 3 | 3 | 3 | -14 | -114 | -127 | -144 |
| Interest | 6 | 7 | 12 | 21 | 26 | 34 | 45 | 1 | 0 | 0 |
| Depreciation | 2 | 2 | 2 | 3 | 3 | 4 | 5 | 6 | 5 | 5 |
| Profit before tax | 10 | 19 | 27 | 28 | 41 | 63 | 4 | -162 | -141 | -147 |
| Tax % | 7 | 26 | 32 | 22 | 20 | 22 | 21 | 0 | 0 | — |
| Net Profit | 10 | 14 | 18 | 22 | 33 | 49 | 4 | -162 | -141 | -147 |
| EPS in Rs | — | — | — | — | — | — | 1.42 | -65.52 | -56.91 | -59.41 |
| Dividend Payout % | 0 | 8 | 12 | 10 | 10 | 0 | 0 | 0 | 0 | — |

### Balance Sheet

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2006 | Mar 2007 | Mar 2008 | Mar 2009 | Mar 2010 | Mar 2011 | Mar 2012 | Jun 2013 | Jun 2014 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Equity Capital | 10 | 11 | 11 | 11 | 11 | 11 | 12 | 12 | 12 |
| Reserves | 5 | 24 | 40 | 59 | 95 | 144 | 169 | 6 | -133 |
| Borrowings | 58 | 67 | 120 | 160 | 195 | 258 | 302 | 307 | 307 |
| Other Liabilities | 43 | 29 | 48 | 55 | 59 | 66 | 68 | 117 | 129 |
| Total Liabilities | 114 | 131 | 219 | 285 | 360 | 478 | 551 | 442 | 315 |
| Fixed Assets | 35 | 30 | 34 | 58 | 67 | 81 | 95 | 88 | 83 |
| CWIP | 0 | 0 | 7 | 5 | 10 | 7 | 7 | 0 | 0 |
| Investments | 0 | 0 | 0 | 0 | 0 | 11 | 11 | 11 | 11 |
| Other Assets | 79 | 101 | 177 | 221 | 283 | 379 | 438 | 344 | 220 |
| Total Assets | 114 | 131 | 219 | 285 | 360 | 478 | 551 | 442 | 315 |

### Cash Flow

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2006 | Mar 2007 | Mar 2008 | Mar 2009 | Mar 2010 | Mar 2011 | Mar 2012 | Jun 2013 | Jun 2014 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash from Operating Activity | -7 | -2 | -16 | 5 | 14 | -5 | 2 | -6 | 2 |
| Cash from Investing Activity | -1 | -1 | -25 | -25 | -30 | -25 | -19 | 0 | 0 |
| Cash from Financing Activity | 9 | 3 | 42 | 21 | 17 | 27 | 16 | 4 | -1 |
| Net Cash Flow | 0 | 0 | 0 | 2 | 2 | -3 | -1 | -2 | 1 |
| Free Cash Flow | -8 | -3 | -29 | -20 | -3 | -20 | -17 | -6 | 1 |
| CFO/OP | -39 | 10 | -20 | 23 | 32 | 2 | 3 | 12 | -21 |

### Ratios

| Item | Mar 2006 | Mar 2007 | Mar 2008 | Mar 2009 | Mar 2010 | Mar 2011 | Mar 2012 | Jun 2013 | Jun 2014 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Debtor Days | 119 | 125 | 140 | 141 | 133 | 143 | 163 | 278 | 2342 |
| Inventory Days | 57 | 58 | 59 | 68 | 67 | 61 | 50 | 68 | 75 |
| Days Payable | 50 | 44 | 41 | 35 | 33 | 29 | 22 | 32 | 434 |
| Cash Conversion Cycle | 127 | 139 | 159 | 174 | 166 | 175 | 191 | 314 | 1983 |
| Working Capital Days | 110 | 131 | 159 | 164 | 165 | 161 | 174 | 224 | 1003 |
| ROCE % | — | 30 | 28 | 25 | 25 | 27 | 14 | -12 | -5 |

## Technical Indicators

Derived from daily closing prices and recomputed each trading session; values move with the market.

- **Overall Signal:** Strong Sell
- **Buy / Neutral / Sell:** 5 / 2 / 12

### Moving Averages — summary: **Strong Sell**

| Indicator | Value | Signal |
| --- | --- | --- |
| SMA (10) | 2 | Sell |
| EMA (10) | 1.94 | Sell |
| SMA (20) | 2.05 | Sell |
| EMA (20) | 2.04 | Sell |
| SMA (50) | 2.31 | Sell |
| EMA (50) | 2.23 | Sell |
| SMA (100) | 2.58 | Sell |
| EMA (100) | 2.37 | Sell |
| SMA (200) | 2.44 | Sell |
| EMA (200) | 2.33 | Sell |

### Oscillators — summary: **Strong Buy**

| Indicator | Value | Signal |
| --- | --- | --- |
| RSI (14) | 28.81 | Buy |
| MACD (12,26,9) | -0.12 | Sell |
| Stochastic (14,3,3) | 5.05 | Buy |
| ADX (14) | 15.76 | Neutral |
| Williams %R (14) | -93.94 | Buy |
| ATR (14) | 0.14 | High Volatility |
| ROC (12) | -13.43 | Sell |
| Stoch RSI (14) | 0 | Buy |
| UO (7,14,28) | 22.7 | Buy |

## Filings & Documents

### Other Documents

| Date | Document |
| --- | --- |
| — | [Disclosures under Reg. 29(1) of SEBI (SAST) Regulations, 2011 29 Jul 2016](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=B92E78E5_4AEE_43F1_85BC_6FF29B5FFF08_104358.pdf) |
| — | [Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011 29 Jul 2016](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=964F1112_4EB0_4919_9A48_606E8A7708C9_104729.pdf) |
| — | [Disclosures under Reg. 29(1) of SEBI (SAST) Regulations, 2011 29 Jul 2016](https://www.bseindia.com/xml-data/corpfiling/CorpAttachment/2016/7/B92E78E5_4AEE_43F1_85BC_6FF29B5FFF08_104358.pdf) |
| — | [Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011 29 Jul 2016](https://www.bseindia.com/xml-data/corpfiling/CorpAttachment/2016/7/964F1112_4EB0_4919_9A48_606E8A7708C9_104729.pdf) |

### Annual Reports

| Date | Document |
| --- | --- |
| from nse | [Annual Report 2011 from nse](https://archives.nseindia.com/annual_reports/AR_TWILITAKA_2010_2011_02112011120202.zip) |
| from nse | [Annual Report 2010 from nse](https://archives.nseindia.com/annual_reports/AR_TWILITAKA_2009_2010_09092010120000.zip) |
| from bse | [Annual Report 2014 from bse](http://www.bseindia.com/bseplus/AnnualReport/506985/5069850614.pdf) |
| from bse | [Annual Report 2012 from bse](https://www.bseindia.com/bseplus/AnnualReport/506985/5069850312.pdf) |
| from bse | [Annual Report 2011 from bse](https://www.bseindia.com/bseplus/AnnualReport/506985/5069850311.pdf) |
| from bse | [Annual Report 2010 from bse](https://www.bseindia.com/bseplus/AnnualReport/506985/5069850310.pdf) |

---

Provenance differs by section. Financial statements, shareholding and filings are as reported in company disclosures to NSE/BSE/SEBI. Price, volume and 52-week levels are exchange market data. Technical indicators are computed by Tapetide from daily closing prices. The Tapetide Score is Tapetide's own analysis. Analyst ratings are third-party estimates, not company statements. All figures are for research and information only and are not investment advice. Generated 2026-09-13T19:41:21.057Z.